Supravalvular aortic stenosis: A splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts

Zsolt Urbán, Virginia V. Michels, Stephen N Thibodeau, Helen Donis-Keller, Katalin Csiszár, Charles D. Boyd

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

We have screened the elastin gene for mutations responsible for supravalvular aortic stenosis (SVAS) in two large, independently collected families with isolated (nonsyndromic) SVAS. By single-strand conformation polymorphism and heteroduplex analysis, we have identified a C to G transversion within the acceptor splice site of exon 16 in SVAS patients from both families. This mutation segregates in both families with high penetrance of SVAS, and all affected individuals carry the mutation. Haplotype analysis by using closely linked polymorphisms, including a previously unreported BfaI restriction fragment length polymorphism within the 3'-UTR of the elastin gene, indicates that the mutations found in the two apparently nonoverlapping kindreds are identical by descent. To study the effect of the mutation on the expression of the mutant allele, we have established a primary skin fibroblast culture from one of the affected individuals. Reverse transcription/polymerase chain reaction analysis of elastin mRNA species indicates that the mutation results in two abnormal elastin mRNA species. One mutant elastin mRNA is generated by the activation of a cryptic splice site that lies within intron 15 and that adds 44 bp of intronic sequence to the sequence encoded by exon 16. This insertion creates a frame shift that results in a 59-amino-acid-long abnormal protein sequence and leads to a termination codon in the mRNA sequence encoded by exon 17. The smaller abnormal mRNA species arises as a consequence of the skipping of exon 16. This study demonstrates, for the first time, the expression of mutant alleles of the elastin gene in patients with isolated SVAS.

Original languageEnglish (US)
Pages (from-to)135-142
Number of pages8
JournalHuman Genetics
Volume104
Issue number2
DOIs
StatePublished - 1999

Fingerprint

Supravalvular Aortic Stenosis
Elastin
Mutation
Exons
Messenger RNA
Genes
RNA Splice Sites
Alleles
Heteroduplex Analysis
Penetrance
Terminator Codon
3' Untranslated Regions
Restriction Fragment Length Polymorphisms
Introns
Haplotypes
Reverse Transcription
Fibroblasts
Amino Acids
Polymerase Chain Reaction
Skin

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Supravalvular aortic stenosis : A splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. / Urbán, Zsolt; Michels, Virginia V.; Thibodeau, Stephen N; Donis-Keller, Helen; Csiszár, Katalin; Boyd, Charles D.

In: Human Genetics, Vol. 104, No. 2, 1999, p. 135-142.

Research output: Contribution to journalArticle

Urbán, Zsolt ; Michels, Virginia V. ; Thibodeau, Stephen N ; Donis-Keller, Helen ; Csiszár, Katalin ; Boyd, Charles D. / Supravalvular aortic stenosis : A splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. In: Human Genetics. 1999 ; Vol. 104, No. 2. pp. 135-142.
@article{48be710d250548ca888ed2ba1460864b,
title = "Supravalvular aortic stenosis: A splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts",
abstract = "We have screened the elastin gene for mutations responsible for supravalvular aortic stenosis (SVAS) in two large, independently collected families with isolated (nonsyndromic) SVAS. By single-strand conformation polymorphism and heteroduplex analysis, we have identified a C to G transversion within the acceptor splice site of exon 16 in SVAS patients from both families. This mutation segregates in both families with high penetrance of SVAS, and all affected individuals carry the mutation. Haplotype analysis by using closely linked polymorphisms, including a previously unreported BfaI restriction fragment length polymorphism within the 3'-UTR of the elastin gene, indicates that the mutations found in the two apparently nonoverlapping kindreds are identical by descent. To study the effect of the mutation on the expression of the mutant allele, we have established a primary skin fibroblast culture from one of the affected individuals. Reverse transcription/polymerase chain reaction analysis of elastin mRNA species indicates that the mutation results in two abnormal elastin mRNA species. One mutant elastin mRNA is generated by the activation of a cryptic splice site that lies within intron 15 and that adds 44 bp of intronic sequence to the sequence encoded by exon 16. This insertion creates a frame shift that results in a 59-amino-acid-long abnormal protein sequence and leads to a termination codon in the mRNA sequence encoded by exon 17. The smaller abnormal mRNA species arises as a consequence of the skipping of exon 16. This study demonstrates, for the first time, the expression of mutant alleles of the elastin gene in patients with isolated SVAS.",
author = "Zsolt Urb{\'a}n and Michels, {Virginia V.} and Thibodeau, {Stephen N} and Helen Donis-Keller and Katalin Csisz{\'a}r and Boyd, {Charles D.}",
year = "1999",
doi = "10.1007/s004390050926",
language = "English (US)",
volume = "104",
pages = "135--142",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Supravalvular aortic stenosis

T2 - A splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts

AU - Urbán, Zsolt

AU - Michels, Virginia V.

AU - Thibodeau, Stephen N

AU - Donis-Keller, Helen

AU - Csiszár, Katalin

AU - Boyd, Charles D.

PY - 1999

Y1 - 1999

N2 - We have screened the elastin gene for mutations responsible for supravalvular aortic stenosis (SVAS) in two large, independently collected families with isolated (nonsyndromic) SVAS. By single-strand conformation polymorphism and heteroduplex analysis, we have identified a C to G transversion within the acceptor splice site of exon 16 in SVAS patients from both families. This mutation segregates in both families with high penetrance of SVAS, and all affected individuals carry the mutation. Haplotype analysis by using closely linked polymorphisms, including a previously unreported BfaI restriction fragment length polymorphism within the 3'-UTR of the elastin gene, indicates that the mutations found in the two apparently nonoverlapping kindreds are identical by descent. To study the effect of the mutation on the expression of the mutant allele, we have established a primary skin fibroblast culture from one of the affected individuals. Reverse transcription/polymerase chain reaction analysis of elastin mRNA species indicates that the mutation results in two abnormal elastin mRNA species. One mutant elastin mRNA is generated by the activation of a cryptic splice site that lies within intron 15 and that adds 44 bp of intronic sequence to the sequence encoded by exon 16. This insertion creates a frame shift that results in a 59-amino-acid-long abnormal protein sequence and leads to a termination codon in the mRNA sequence encoded by exon 17. The smaller abnormal mRNA species arises as a consequence of the skipping of exon 16. This study demonstrates, for the first time, the expression of mutant alleles of the elastin gene in patients with isolated SVAS.

AB - We have screened the elastin gene for mutations responsible for supravalvular aortic stenosis (SVAS) in two large, independently collected families with isolated (nonsyndromic) SVAS. By single-strand conformation polymorphism and heteroduplex analysis, we have identified a C to G transversion within the acceptor splice site of exon 16 in SVAS patients from both families. This mutation segregates in both families with high penetrance of SVAS, and all affected individuals carry the mutation. Haplotype analysis by using closely linked polymorphisms, including a previously unreported BfaI restriction fragment length polymorphism within the 3'-UTR of the elastin gene, indicates that the mutations found in the two apparently nonoverlapping kindreds are identical by descent. To study the effect of the mutation on the expression of the mutant allele, we have established a primary skin fibroblast culture from one of the affected individuals. Reverse transcription/polymerase chain reaction analysis of elastin mRNA species indicates that the mutation results in two abnormal elastin mRNA species. One mutant elastin mRNA is generated by the activation of a cryptic splice site that lies within intron 15 and that adds 44 bp of intronic sequence to the sequence encoded by exon 16. This insertion creates a frame shift that results in a 59-amino-acid-long abnormal protein sequence and leads to a termination codon in the mRNA sequence encoded by exon 17. The smaller abnormal mRNA species arises as a consequence of the skipping of exon 16. This study demonstrates, for the first time, the expression of mutant alleles of the elastin gene in patients with isolated SVAS.

UR - http://www.scopus.com/inward/record.url?scp=0032973922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032973922&partnerID=8YFLogxK

U2 - 10.1007/s004390050926

DO - 10.1007/s004390050926

M3 - Article

C2 - 10190324

AN - SCOPUS:0032973922

VL - 104

SP - 135

EP - 142

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 2

ER -